At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
Policosanol +2 moredrug
Likely dose
Policosanol 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of Policosanol Monotherapy and When Added to Chronic Statin Therapy: A Pilot Study
In Brief
A clinical study evaluating Policosanol, Placebo, and 1 other intervention for High Cholesterol. Completed, enrolled 54 participants across 1 site.
Detailed Summary
To determine the effects of policosanol on the cholesterol profile.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHigh Cholesterol
CountriesUnited States
CollaboratorsMarcor Development Corporation
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
First PostedAug 2007
Primary CompletionMar 2010
Study CompletionMay 2010
TodayJul 2026
First PostedAug 2, 2007
Enrollment StartJul 1, 2007
Primary CompletionMar 1, 2010
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 18.9 years ago
Interventions
Policosanoldrug
Policosanol 20 mg daily
Placeboother
Placebo daily
Policosanol Plus Already In Use Statin Therapydrug
Policosanol 20 mg daily Statin Therapy